Related references
Note: Only part of the references are listed.The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
Zobair M. Younossi et al.
HEPATOLOGY (2023)
Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry
Andreas Geier et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2023)
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
Zobair M. Younossi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Mary E. Rinella et al.
Annals of Hepatology (2023)
Antifibrotic Drug Nintedanib Inhibits CSF1R to Promote IL-4-associated Tissue Repair Macrophages
Carolin K. Watson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2023)
Plasticity between type 2 innate lymphoid cell subsets and amphiregulin expression regulates epithelial repair in biliary atresia
Abigail E. Russi et al.
HEPATOLOGY (2023)
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosis
Jan Raabe et al.
HEPATOLOGY (2023)
Engineering the IL-4/IL-13 axis for targeted immune modulation
Zachary J. J. Bernstein et al.
IMMUNOLOGICAL REVIEWS (2023)
Role of the IL-33/ST2 Activation Pathway in the Development of the Hepatic Fibrosis Induced by Schistosoma mansoni Granulomas in Mice
Laura Maggi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
The Role of IL-13 and IL-4 in Adipose Tissue Fibrosis
Lilli Arndt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Interleukin-13 contributes to the occurrence of oral submucosal fibrosis
Liping Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)
IL-13RA2 downregulation in fibroblasts promotes keloid fibrosis via JAK/STAT6 activation
Hua Chao et al.
JCI INSIGHT (2023)
A global action agenda for turning the tide on fatty liver disease
Jeffrey V. Lazarus et al.
HEPATOLOGY (2023)
Altered Fear Behavior in Aeroallergen House Dust Mite Exposed C57Bl/6 Mice: A Model of Th2-skewed Airway Inflammation
E. Allgire et al.
NEUROSCIENCE (2023)
Eosinophils participate in modulation of liver immune response and tissue damage induced by Schistosoma mansoni infection in mice
Vinicius Gustavo de Oliveira et al.
CYTOKINE (2022)
Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review
Elke Roeb
VISCERAL MEDICINE (2022)
Updated S2k Guideline non-alcoholic Fatty Liver Disease from the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) April 2022-AWMF Register Number: 021-025
E. Roeb et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2022)
Liver group 2 innate lymphoid cells regulate blood glucose levels through IL-13 signaling and suppression of gluconeogenesis
Masanori Fujimoto et al.
NATURE COMMUNICATIONS (2022)
Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice
Mohamed Abd Allah et al.
The Egyptian journal of immunology / Egyptian Association of Immunologists (2022)
IL13 and periostin in active fibrogenic areas of the extrahepatic bile ducts in biliary atresia patients
Yuki Sengoku et al.
PEDIATRIC SURGERY INTERNATIONAL (2022)
Destructive fibrotic teamwork: how both microenvironment stiffness and profibrotic interleukin 13 impair alveolar macrophage phenotype and function
Kartik Bomb et al.
BIOMATERIALS SCIENCE (2022)
IL-13 Controls IL-33 Activity through Modulation of ST2
Melvin Zhang et al.
JOURNAL OF IMMUNOLOGY (2021)
Chronic inflammation involves CCL11 and IL-13 to facilitate the development of liver cirrhosis and fibrosis in chronic hepatitis B virus infection
Sui-Weng Wong et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2021)
Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach
Mercedes Perez-Carreras et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
The Genetics of Human Schistosomiasis Infection Intensity and Liver Disease: A Review
Estelle M. Mewamba et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis
Dan J. K. Yombo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Non-alcoholic fatty liver diseases: current challenges and future directions
Elke Roeb
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Genistein and exercise treatment reduced NASH related HDAC3, IL-13 and MMP-12 expressions in ovariectomized rats fed with high fat high fructose diet
Namthip Witayavanitkul et al.
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE (2021)
The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
Julie K. Nguyen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)
IL-13-driven alterations in hepatic cholesterol handling contributes to hypercholesterolemia in a rat model of minimal change disease
Lauretta D. Low et al.
CLINICAL SCIENCE (2020)
Interleukin-13 ameliorates postischemic hepatic gluconeogenesis and hyperglycemia in rat model of stroke
Keng-Ying Liao et al.
METABOLIC BRAIN DISEASE (2020)
IL-13 as Target to Reduce Cholestasis and Dysbiosis inAbcb4Knockout Mice
Luisa Hahn et al.
CELLS (2020)
Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis
Marwa O. El-Derany
BIOLOGY-BASEL (2020)
Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis
Shimpei Matsui et al.
CANCER SCIENCE (2019)
IL-13 signaling through IL-13 receptor 2 mediates airway epithelial wound repair
S. Jasemine Yang et al.
FASEB JOURNAL (2019)
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Giancarlo Marone et al.
FRONTIERS IN PHARMACOLOGY (2019)
Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis
S. M. Krug et al.
MUCOSAL IMMUNOLOGY (2018)
IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal
Shih-Yen Weng et al.
EBIOMEDICINE (2018)
Emerging Role of HMGB1 in the Pathogenesis of Schistosomiasis Liver Fibrosis
Amanda R. R. Vicentino et al.
FRONTIERS IN IMMUNOLOGY (2018)
From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions
Tiziana Caputo et al.
FEBS LETTERS (2017)
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Kevin M. Hart et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Effects of IL-13 on TGF-β and MMP-1 in periodontitis
A. Beklen
BIOTECHNIC & HISTOCHEMISTRY (2017)
Interleukin-13 Activates Distinct Cellular Pathways Leading to Ductular Reaction, Steatosis, and Fibrosis
Richard L. Gieseck et al.
IMMUNITY (2016)
Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
Meric Erikci Ertunc et al.
JOURNAL OF LIPID RESEARCH (2016)
Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis
Nada Pejnovic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Genetic diversity, multiplicity of infection and population structure of Schistosoma mansoni isolates from human hosts in Ethiopia
Mulugeta Aemero et al.
BMC GENETICS (2015)
IL-3 synergises with basophil-derived IL-4 and IL-13 to promote the alternative activation of human monocytes
Francesco Borriello et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis B
Zhiqing Yang et al.
INNATE IMMUNITY (2015)
Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice
P. Darkhal et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
Ilija Jeftic et al.
MOLECULAR MEDICINE (2015)
Hepatic myofibroblasts derived from Schistosoma mansoni-infected mice are a source of IL-5 and eotaxin: controls of eosinophil populations in vitro
Ligia Almeida Paiva et al.
Parasites & Vectors (2015)
An IL-13 Promoter Polymorphism Associated with Liver Fibrosis in Patients with Schistosoma japonicum
Xin Long et al.
PLOS ONE (2015)
Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis
R. Candia et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Silymarin Reduces Profibrogenic Cytokines and Reverses Hepatic Fibrosis in Chronic Murine Schistosomiasis
Hilton Antonio Mata-Santos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Interleukin-13 Deficiency Aggravates Healing and Remodeling in Male Mice After Experimental Myocardial Infarction
Ulrich Hofmann et al.
CIRCULATION-HEART FAILURE (2014)
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation
Jun Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Direct control of hepatic glucose production by interleukin-13 in mice
Kristopher J. Stanya et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology
Oscar M. Pello et al.
BLOOD (2012)
The Interleukin 13 (IL-13) Pathway in Human Macrophages Is Modulated by MicroRNA-155 via Direct Targeting of Interleukin 13 Receptor α1 (IL13Rα1)
Rocio T. Martinez-Nunez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling
Hergen Spits et al.
NATURE IMMUNOLOGY (2011)
The Etiology of Liver Damage Imparts Cytokines Transforming Growth Factor β1 or Interleukin-13 as Driving Forces in Fibrogenesis
Hong-Lei Weng et al.
HEPATOLOGY (2009)
Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes
Xin Yuan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection
Jun-ping Shi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model
Takeshi Shimamura et al.
JOURNAL OF IMMUNOLOGY (2008)
Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function
F. Heller et al.
MUCOSAL IMMUNOLOGY (2008)
Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity
RM Reiman et al.
INFECTION AND IMMUNITY (2006)
ERK1/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo
PJ Lee et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
IL-13 signaling through the IL-13 alpha 2 receptor is involved in induction of TGF-beta 1 production and fibrosis
S Fichtner-Feigl et al.
NATURE MEDICINE (2006)
Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells
R Sugimoto et al.
LIVER INTERNATIONAL (2005)
Opposing roles for IL-13 and IL-13 receptor α2 in health and disease
MM Mentink-Kane et al.
IMMUNOLOGICAL REVIEWS (2004)
Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation
Z Zhu et al.
SCIENCE (2004)
Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-γ
M Ahdieh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2001)
CD40L-Induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13
DMA Bullens et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2001)
Expression and contribution of endogenous IL-13 in an experimental model of sepsis
A Matsukawa et al.
JOURNAL OF IMMUNOLOGY (2000)